Letter: Management of lipoatrophic diabetes.
D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D008060:Lipodystrophy / Q000188:drug therapy* / Q000503:physiopathology; D010868:Pimozide / Q000627:therapeutic use*
D010868:Pimozide